U.S. Software Stock News

Quest Diagnostics (DGX) just deepened its neurological testing ambitions through a new collaboration with Octave Bioscience, giving nationwide access to Octave’s multiple sclerosis disease activity blood test via Quest’s 7,000 collection sites. See our latest analysis for Quest Diagnostics. That strategic push into neurology comes as sentiment around Quest has been quietly improving, with the share price at $182.56 and a strong year to date share price return of 20.93 percent, backed by a 5...

Rivian recently held its first Autonomy & AI Day, unveiling its custom 5nm Rivian Autonomy Processor (RAP1), third-generation Autonomy Compute Module (ACM3), LiDAR-enabled Gen 3 hardware for future R2 models, an AI-driven Large Driving Model, and an Autonomy+ subscription service launching in early 2026. By shifting to in-house silicon and an AI-first software stack, Rivian is trying to turn autonomy and connected services into a long-term, higher-margin revenue engine rather than relying...

How Has Cisco Systems Stock Been Performing? Cisco Systems has quietly been rewarding patient shareholders, with the stock up 36.1% over the past year and 98.4% over the last five years, turning what many once saw as a mature tech name into a solid compounder. Even in the short term, the picture is constructive, with a 5.2% gain over the last 30 days, a modest 0.2% pullback over the past week, and the shares recently closing around $77.80. This backdrop matters because it shapes how investors...

Recently, CSX reported its fastest train velocity since early 2021 and completed major projects such as the Howard Street Tunnel and Blue Ridge subdivision ahead of schedule, enhancing network capacity and resilience. At the same time, the company is tightening its cost base and governance, including shutting an 84-year-old corporate aviation department shortly after appointing new CEO Steve Angel, signaling a sharper focus on efficiency and capital discipline. Now we’ll examine how CSX’s...

Assessing Beyond Meat after a steep slide Beyond Meat (BYND) shares keep grinding lower, recently closing near 1 dollar, and that kind of drop naturally raises the question: is this a value opportunity or a value trap for patient investors? See our latest analysis for Beyond Meat. The latest slide to around 1.09 dollars caps a brutal stretch, with a roughly 72 percent 1 year total shareholder return loss and even steeper multiyear declines in the share price return, signaling fading momentum...

Penguin Solutions, Inc. recently introduced its SMART 64GB DDR5-6400 ECC CSODIMM modules, expanding its DDR5 SODIMM lineup for high-performance computing across industrial, edge, telecom, and networking applications, with commercial- and industrial-temperature options for harsh environments. The addition of a 64GB CSODIMM with integrated clock driver and error correction meaningfully broadens Penguin’s memory portfolio, giving system designers more flexibility to optimize density, speed, and...

Wondering if ImmunityBio at around $2.36 is a speculative trap or a misunderstood bargain? You are not alone, and that is exactly what this breakdown is here to unpack. Despite a bruising longer term record, with the share price down about 17.8% over the last year and 63.4% over three years, the stock has shown signs of life recently, gaining roughly 3.1% in the past week and 14.6% over the last month, while still sitting 8.2% lower year to date. Those moves have come as investors continue...

If you have been wondering whether Capricor Therapeutics is still a smart buy after its big run, you are not alone. This stock has quickly moved from under the radar to front and center on a lot of watchlists. The share price has dipped 3.2% over the last week, but that small pullback sits on top of a 343.3% gain in the last month and a 96.2% return over the past year, with long term holders still up 593.9% over 3 years and 524.0% over 5 years. Behind those moves, investors have been...

If you have ever looked at Main Street Capital and wondered whether the current price really reflects its underlying value, this breakdown is for you. The stock has climbed to around $62.05, delivering about 2.2% over the last week, 4.9% in the last month, 4.7% year to date, and 19.9% over the past year, with multi year gains of 114.1% over 3 years and 190.8% over 5 years reshaping how investors see its potential. Recent headlines have focused on Main Street Capital expanding its portfolio...

Teradyne (TER) just put a bigger flag in U.S. manufacturing, with Teradyne Robotics planning a new operations hub in Wixom, Michigan, to build cobots and support customers across North America. See our latest analysis for Teradyne. The Wixom hub builds on a big year for Teradyne, where enthusiasm around AI driven semiconductor demand and robotics has helped drive a roughly 72 percent 3 month share price return and a strong multi year total shareholder return, even after the latest pullback to...

Recent stock performance and context Trump Media and Technology Group (DJT) has been drifting lower, with the stock down about 16% over the past month and more than 37% over the past 3 months. This has prompted fresh questions about valuation and trajectory. See our latest analysis for Trump Media & Technology Group. Zooming out, the share price has slid to about $10.65 and the sharp year to date share price return decline, alongside a steep 1 year total shareholder loss, suggests momentum is...

Natural Grocers by Vitamin Cottage (NGVC) has wrapped up FY 2025 with fourth quarter revenue of $336.1 million and basic EPS of $0.51, alongside trailing twelve month revenue of about $1.3 billion and EPS of $2.02. Over the last few quarters the company has seen revenue move from $322.7 million in Q4 2024 to $336.1 million in Q4 2025, while quarterly EPS stepped up from $0.40 to roughly the low $0.50s as net income climbed from $9.0 million to $11.8 million. With net margin rising from 2.7%...

Kite, a Gilead Sciences (GILD) company, just released new analysis showing its CAR T therapy Yescarta delivers consistent benefits as a second line option for difficult large B cell lymphoma cases. See our latest analysis for Gilead Sciences. That stronger oncology story is quietly reshaping how investors see Gilead, with the share price at $120.4 after a softer recent patch but a robust year to date share price return of 31.04 percent, backed by a 1 year total shareholder return of 33.86...

Why Peabody Energy is Back on Watchlists Peabody Energy (BTU) has quietly turned into a strong performer over the past 3 months, with the stock up roughly 58%, even as its latest annual results still show a small net loss. See our latest analysis for Peabody Energy. Zooming out, that recent strength comes after a choppy year. Peabody’s share price is now at $29.15, with momentum clearly rebuilding following a strong 90 day share price return alongside a solid five year total shareholder...

Wondering if Eli Lilly is still worth buying after its monster run, or if the upside has already been priced in? You are not alone, and that is exactly what this article aims to unpack. The stock has climbed 1.7% over the last week, 1.0% in the past month, and is up a hefty 32.1% year to date, building on a 31.2% gain over the last year and an astonishing 531.7% over five years. A big part of this momentum has been driven by excitement around Eli Lilly's obesity and diabetes treatments,...

Wondering if Arbor Realty Trust at around $8.87 is a beaten down opportunity or a value trap? Let us unpack what the numbers are really saying about the stock. Despite a modest 0.2% gain over the last 7 days, the share price is still down 3.8% over 30 days, 35.6% year to date, and 30.6% over the past year, with only a 6.9% gain over five years. This naturally raises questions about whether the market has become too pessimistic. Recently, the stock has been in the spotlight as investors...

Bio Green Med Solution, Inc.'s (NASDAQ:BGMS) value has fallen 13% in the last week, but insiders who sold US$4.8m worth...

Frequency Electronics (FEIM) just posted Q2 2026 results with revenue of about $17.1 million and basic EPS of roughly $0.18, putting fresh numbers on the board for both the top and bottom line. The company has seen quarterly revenue move from around $15.8 million in Q2 2025 to $17.1 million this quarter, while basic EPS has shifted from approximately $0.28 to $0.18 over the same period, against a trailing-12-month net income backdrop of about $21.0 million. Taken together, the latest print...

Earlier this month, Intuitive Machines acquired Lanteris Space Systems, moving to offer end-to-end space services spanning multiple orbital regimes and mission types. This move effectively recasts Intuitive Machines as a full-service space contractor, broadening its role across civil, defense, and commercial space programs. We’ll now examine how the Lanteris acquisition, and Intuitive Machines’ push into full-service space contracting, reshapes its investment narrative. AI is about to change...

In early December 2025, Business Alliance Financial Services (BAFS) announced its integration with Fiserv’s Portico® account processing system, giving Portico-using credit unions broader access to BAFS’ BLAST® commercial loan origination and accounting platform across the full lending lifecycle. This integration underscores how Fiserv’s core processing relationships can deepen its role in commercial lending technology for credit unions, potentially enhancing client stickiness and cross‑sell...

If you are wondering whether QUALCOMM at around $178 a share is still a smart buy or if the best gains are already behind it, you are not alone. That question is exactly what this valuation deep dive will unpack. The stock has climbed about 2.0% over the last week, 0.9% over the past month, and is up 16.0% year to date. This adds to a solid 15.0% gain over the last year and a 66.6% gain over three years. Recent headlines have focused on QUALCOMM doubling down on AI at the edge, from...

Broadcom (AVGO) kicked off FY 2025 with fiscal Q4 revenue of about $18.0 billion and basic EPS of $1.80, capping off a year in which trailing 12 month revenue reached roughly $63.9 billion and EPS climbed to $4.91 as reported earnings jumped 275.4% with net margins advancing to 36.2% from 12% the prior year. The company has seen revenue move from around $51.6 billion on a trailing 12 month basis in late 2024 to $63.9 billion by Q4 2025, while net income over the same window expanded from $6.2...

Equinix (EQIX) just put a major leadership transition on the calendar, with longtime CFO Keith Taylor planning to retire in 2026 while staying on as a Special Advisor to support the handover. See our latest analysis for Equinix. The leadership change comes at a tricky moment for sentiment, with the share price at $750.32 and a year to date share price return of negative 20.54 percent. Even though the three year total shareholder return remains positive, this suggests longer term momentum is...

Wondering if General Mills at around $46.69 is a bargain hiding in plain sight or a classic value trap in the making? This article is designed to help you figure that out with a clear, valuation-first lens. Despite a modest 1.7% gain over the last 7 days and a flat 0.4% over 30 days, the stock is still down a steep 26.5% year to date and 26.8% over the last year, which naturally raises questions about whether sentiment has overshot the fundamentals. Recently, investors have been rethinking...